Pharmacology & ToxicologybioRxivPreprint
Targeted Alpha Therapy with Ac-Macropa-Isatuximab for CD38-positive Hematological Malignancies
Natalia Herrero Álvarez, David Bauer, Alexa L. Michel…·Jason Stuart Lewis
This paper evaluates [225Ac]Ac-Macropa-Isatuximab as a targeted alpha therapy for CD38-positive hematological malignancies, showing significant tumor reduction and survival extension with minimal toxicity.
1 citation